Radius Health to Present at the Credit Suisse 25th Annual Healthcare Conference
November 01 2016 - 6:19PM
Radius Health, Inc. (Nasdaq:RDUS), a science-driven
biopharmaceutical company that is committed to developing
innovative therapeutics in the areas of osteoporosis, oncology and
endocrine diseases, today announced that President and Chief
Executive Officer, Robert E. Ward, will present at the Credit
Suisse 25th Annual Healthcare Conference in Scottsdale, AZ on
Monday, November 7, 2016 at 11:00 a.m. Pacific Time/2:00 p.m.
Eastern Time.
The Company's presentation will be webcast live on the Company's
website at www.radiuspharm.com, where a replay of the presentation
will also be available. The Company will post a copy of the
presentation materials on its website, www.radiuspharm.com, prior
to the start of the presentation.
About Radius
Radius is a science-driven biopharmaceutical company that is
committed to developing innovative therapeutics in the areas of
osteoporosis, oncology and endocrine diseases. Radius' lead product
candidate, the investigational drug abaloparatide for subcutaneous
injection, has completed Phase 3 development for potential use in
the reduction of fracture risk in postmenopausal women with
osteoporosis. Radius' Marketing Authorisation Application (MAA) for
abaloparatide-SC for the treatment of postmenopausal women with
osteoporosis is under regulatory review in Europe and a New Drug
Application (NDA) has been accepted for filing by the FDA with a
PDUFA date of March 30, 2017.The Radius clinical pipeline also
includes an investigational abaloparatide transdermal patch for
potential use in osteoporosis and the investigational drug RAD1901
for potential use in hormone-driven and/or hormone-resistant breast
cancer, and vasomotor symptoms in postmenopausal women. Radius'
preclinical pipeline includes RAD140, a non-steroidal, selective
androgen receptor modulator (SARM) under investigation for
potential use in cancer. For more information, please visit
www.radiuspharm.com
Investor Relations Contact:
Barbara Ryan
Email: bryan@radiuspharm.com
Phone: 203-274-2825
Media Contact:
Lori Gorski
Email: lgorski@radiuspharm.com
Phone: 617-551-4096
Radius Recycling (NASDAQ:RDUS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Radius Recycling (NASDAQ:RDUS)
Historical Stock Chart
From Sep 2023 to Sep 2024